{"id":49,"date":"2024-11-18T12:28:41","date_gmt":"2024-11-18T12:28:41","guid":{"rendered":"https:\/\/www.naglazyme.com\/en-us\/?page_id=49"},"modified":"2026-03-12T09:45:01","modified_gmt":"2026-03-12T09:45:01","slug":"receiving-naglazyme","status":"publish","type":"page","link":"https:\/\/www.naglazyme.com\/en-us\/receiving-naglazyme\/","title":{"rendered":"Receiving NAGLAZYME"},"content":{"rendered":"
\n
\n
\n <\/div>\n <\/div>\n<\/div>\n\n
\n
\n
\n <\/div>\n <\/div>\n<\/div>\n\n
\n
\n
\n \n
\n

Receiving NAGLAZYME\u00ae<\/sup> (galsulfase)<\/h1>\n

Once you\u2019ve been prescribed NAGLAZYME\u00ae<\/sup> (galsulfase), it is important to start the treatment as soon as you can. And once you start, it is important to keep getting your treatments.<\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n

\n
\n\t\t
\n\t\t \t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t

In a study of patients receiving NAGLAZYME for 96 weeks, patients received 98% of scheduled infusions and saw sustained improvements in endurance.1,2<\/sup><\/h4>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n
\n
\n
\n \n
\n

BioMarin RareConnections\u2122: Uncommon Support for MPS VI (or Maroteaux-Lamy syndrome)<\/h2>\n

Rare diseases like MPS VI can bring uncommon challenges. BioMarin RareConnections is here to help you meet these challenges with the resources and assistance you need to gain access to NAGLAZYME. When you enroll with BioMarin RareConnections, you will be connected with a Case Manager who can provide a wide array of personalized support services.<\/p>\n

Our dedicated and experienced Case Magangers will provide guidance on how you can gain access to NAGLAZYME by:<\/p>\n